A miRNA signature of prion induced neurodegeneration

Reuben Saba1, Chelsey D Goodman, Rhiannon L C H Huzarewich

  • 1Molecular PathoBiology, National Microbiology Laboratory, Canadian Science Center for Human and Animal Health, Public Health Agency of Canada, Winnipeg, Canada.

Plos One
|November 7, 2008
PubMed

Insights

This study identified 15 microRNAs (miRNAs) with altered expression in scrapie-infected mouse brains, suggesting a specific miRNA signature in prion-induced neurodegeneration and potential roles in disease pathways.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of cellular processes.
  • While miRNAs are known to influence neuronal development, their role in neurodegeneration remains largely unexplored.

Purpose of the Study:

  • To investigate miRNA expression changes in the brain during prion-induced neurodegeneration (scrapie).
  • To identify specific miRNAs and their potential gene targets involved in disease progression.

Main Methods:

  • Microarray and RT-PCR profiling of miRNA expression in scrapie-infected mouse brains.
  • Computational prediction of miRNA gene targets.
  • Integration of miRNA and mRNA profiling with bioinformatic and biochemical validation.

Main Results:

  • Fifteen miRNAs were found to be differentially expressed in scrapie-infected mice.
  • A subset of miRNAs, including miR-342-3p and miR-146a, were significantly upregulated, while others like miR-338-3p were downregulated.
  • Computational analysis predicted numerous gene targets, with significant overlap with genes already known to be dysregulated in mouse scrapie.
  • Correlations were identified between miRNA expression and targets in protein degradation, cell death, synapse function, and neurogenesis pathways.

Conclusions:

  • A unique subset of differentially expressed miRNAs characterizes prion-induced neurodegeneration.
  • These dysregulated miRNAs and their predicted targets likely play a role in the molecular mechanisms underlying scrapie pathogenesis.
  • The findings highlight the potential of miRNAs as biomarkers and therapeutic targets in neurodegenerative diseases.